Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner bought 7,500,000 shares of the business’s stock in a transaction that occurred on Friday, March 28th. The stock was acquired at an average cost of A$0.01 ($0.01) per share, with a total value of A$82,500.00 ($51,562.50).
James Garner also recently made the following trade(s):
- On Wednesday, February 26th, James Garner purchased 39,500,000 shares of Percheron Therapeutics stock. The stock was bought at an average price of A$0.01 ($0.01) per share, with a total value of A$474,000.00 ($296,250.00).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Recommended Stories
- Five stocks we like better than Percheron Therapeutics
- Why is the Ex-Dividend Date Significant to Investors?
- Berkshire Hathaway Gains Defy Stock Market Slump
- What Is WallStreetBets and What Stocks Are They Targeting?
- Palantir Stock Builds Momentum on New Partnership
- How to Invest in Small Cap Stocks
- Tech Sell-Off Makes Microsoft Stock Look Like a Steal
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
